Register for free to
view the full innovation profile.
A digital monitoring technology providing insights into patient's disease progression by continuous monitoring and generating insights used by clinicians to provide interventions
About
Kinexcs uses an AI-driven digital therapist and wearable technologies to reduce the burden of musculoskeletal conditions, which affects about 25% of the global population, or 1.71 billion people. Their 1st product, KIMIA Knee Recovery Management Solution, is the world’s 1st continuous monitoring device for the knee joint, originally launched in Q2 2021 and has booked initial revenues from large implant companies and hospitals. Currently, it is deployed in some of the largest public hospitals in Singapore. KIMIA a proprietary sensing technology (based on >20 patents) which provides the world's first continuous joint range of motion monitoring capability. The product was the National Winner and International Top 20 of the prestigious James Dyson Award 2020. The 2nd product of the company, KIMIA Home, is a digital therapist in the form of a mobile app capable of providing real-time exercise guidance and feedback using computer vision and AI.
Key Benefits
(1) AI-driven continuous monitoring that enables timely insights into disease progression and interventions (2) Improved patient experience, motivation and compliance. Reduced complications during an episode of care. (3) Reduced Costs, improved convenience and quality of life.
Applications
(a) Pain relief for chronic musculoskeletal patients (b) Post-operative recovery management for knee surgeries (c) Enhanced engagement and productivity for employees